Dogwood Therapeutics, Stock Buy Hold or Sell Recommendation
| DWTX Stock | 12.76 0.75 6.24% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Dogwood Therapeutics, is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Dogwood Therapeutics, given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Dogwood Therapeutics,, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Dogwood Therapeutics, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Dogwood Stock please use our How to Invest in Dogwood Therapeutics, guide. In addition, we conduct extensive research on individual companies such as Dogwood and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Dogwood Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Dogwood |
Execute Dogwood Therapeutics, Buy or Sell Advice
The Dogwood recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dogwood Therapeutics,. Macroaxis does not own or have any residual interests in Dogwood Therapeutics, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dogwood Therapeutics,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Dogwood Therapeutics, Trading Alerts and Improvement Suggestions
| Dogwood Therapeutics, is way too risky over 90 days horizon | |
| Dogwood Therapeutics, appears to be risky and price may revert if volatility continues | |
| Dogwood Therapeutics, has high likelihood to experience some financial distress in the next 2 years | |
| Dogwood Therapeutics, was previously known as VIRI Old and was traded on NASDAQ Exchange under the symbol VIRI. | |
| Net Loss for the year was (5.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dogwood Therapeutics, generates negative cash flow from operations | |
| Dogwood Therapeutics, has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Insider Trading |
Dogwood Therapeutics, Returns Distribution Density
The distribution of Dogwood Therapeutics,'s historical returns is an attempt to chart the uncertainty of Dogwood Therapeutics,'s future price movements. The chart of the probability distribution of Dogwood Therapeutics, daily returns describes the distribution of returns around its average expected value. We use Dogwood Therapeutics, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dogwood Therapeutics, returns is essential to provide solid investment advice for Dogwood Therapeutics,.
| Mean Return | 5.77 | Value At Risk | -14.61 | Potential Upside | 40.54 | Standard Deviation | 48.64 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dogwood Therapeutics, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dogwood Therapeutics, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dogwood Therapeutics, or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dogwood Therapeutics,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dogwood stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 4.73 | |
β | Beta against Dow Jones | 11.43 | |
σ | Overall volatility | 51.41 | |
Ir | Information ratio | 0.12 |
Dogwood Therapeutics, Volatility Alert
Dogwood Therapeutics, is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dogwood Therapeutics,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dogwood Therapeutics,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dogwood Therapeutics, Fundamentals Vs Peers
Comparing Dogwood Therapeutics,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dogwood Therapeutics,'s direct or indirect competition across all of the common fundamentals between Dogwood Therapeutics, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dogwood Therapeutics, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dogwood Therapeutics,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Dogwood Therapeutics, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dogwood Therapeutics, to competition |
| Fundamentals | Dogwood Therapeutics, | Peer Average |
| Net Income | (5.3 M) | 570.98 M |
| Total Debt | 358.55 K | 5.32 B |
| Cash Flow From Operations | (4.87 M) | 971.22 M |
| Number Of Employees | 4 | 18.84 K |
| Total Asset | 4.17 M | 29.47 B |
| Retained Earnings | (61.47 M) | 9.33 B |
| Working Capital | 3.81 M | 1.48 B |
| Net Asset | 4.17 M |
Note: Insider Trading [view details]
Dogwood Therapeutics, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dogwood . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 161508.0 | |||
| Daily Balance Of Power | 0.2778 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 13.27 | |||
| Day Typical Price | 13.1 | |||
| Price Action Indicator | (0.13) | |||
| Period Momentum Indicator | 0.75 |
About Dogwood Therapeutics, Buy or Sell Advice
When is the right time to buy or sell Dogwood Therapeutics,? Buying financial instruments such as Dogwood Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dogwood Therapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 239 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.